Valentina Fanotto
Overview
Explore the profile of Valentina Fanotto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
555
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fanotto V, Rossini D, Casagrande M, Bergamo F, Spagnoletti A, Santini D, et al.
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001711
Background: The decision to resect or not the primary tumor in asymptomatic patients with synchronous metastatic colorectal cancer (mCRC) is a complex and challenging issue for oncologists, especially when an...
2.
Fanotto V, Salani F, Vivaldi C, Scartozzi M, Ribero D, Puzzoni M, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765854
The management of the primary tumor in metastatic colorectal, gastric and pancreatic cancer patients may be challenging. Indeed, primary tumor progression could be associated with severe symptoms, compromising the quality...
3.
Moretto R, Germani M, Giordano M, Conca V, Proietti A, Niccoli C, et al.
Br J Cancer
. 2023 Feb;
128(7):1391-1399.
PMID: 36759721
Background: Trop-2 and Nectin-4 are transmembrane proteins overexpressed in many tumours and targets of antibody-drug conjugates (ADC). In metastatic colorectal cancer (mCRC), the role of Trop-2 and Nectin-4 has been...
4.
Di Nardo P, Garattini S, Torrisi E, Fanotto V, Miolo G, Buonadonna A, et al.
Cancers (Basel)
. 2022 Mar;
14(6).
PMID: 35326652
Methods: Scientific literature was evaluated to find phase II or phase III clinical trials on systemic treatment for advanced SBA. MeSH terms were selected and combined for the initial search,...
5.
Zanchetta M, Iacuzzi V, Posocco B, Bortolin G, Poetto A, Orleni M, et al.
PLoS One
. 2021 Oct;
16(10):e0259137.
PMID: 34699578
Lenvatinib (LENVA) is an oral antineoplastic drug used for the treatment of hepatocellular carcinoma and thyroid carcinoma. LENVA therapeutic drug monitoring (TDM) should be mandatory for a precision medicine to...
6.
Bonotto M, Basile D, Gerratana L, Bartoletti M, Lisanti C, Pelizzari G, et al.
Future Oncol
. 2020 Jun;
16(27):2059-2073.
PMID: 32598185
A monitoring strategy for metastatic breast cancer patients (M-MBC) has been little studied. This retrospective study analyzed a consecutive cohort of 382 MBC patients to analyze different M-MBC strategies to...
7.
De Re V, Caggiari L, De Zorzi M, Fanotto V, Miolo G, Puglisi F, et al.
Infect Agent Cancer
. 2020 Jun;
15:42.
PMID: 32582365
Background: EBV produces miRNAs with important functions in cancer growth, tumor invasion and host immune surveillance. The discovery of EBV miR-BARTs is recent, and most of their functions are still...
8.
Basile D, Bartoletti M, Polano M, Bortot L, Gerratana L, Di Nardo P, et al.
Clin Nutr
. 2020 Jun;
40(1):286-294.
PMID: 32546390
Background: Body composition, has been established as a risk factor for colorectal cancer diagnosis and disease progression. Aim of this study was to investigate the prognostic role of adiposity, especially...
9.
Gerratana L, Basile D, Toffoletto B, Bulfoni M, Zago S, Magini A, et al.
Sci Rep
. 2020 Apr;
10(1):7010.
PMID: 32332763
High neutrophil to lymphocyte ratio (NLR) and monocyte to lymphocyte ratio (MLR) are respectively associated with systemic inflammation and immune suppression and have been associated with a poor outcome. Plasmatic...
10.
Basile D, Garattini S, Corvaja C, Montico M, Cortiula F, Pelizzari G, et al.
Oncologist
. 2020 Mar;
25(8):661-668.
PMID: 32202020
Background: Monocyte-to-lymphocyte ratio (MLR) and lactate dehydrogenase (LDH) levels are circulating biomarkers that provide information about tumor-related inflammation and immune suppression. This study aimed to evaluate the prognostic role of...